|
Measurement Of Serum Levels Of Two Antiepileptic Drugs During Conversion In Patients With Epilepsy. Clinical Trials References presented on Clinical Trials Search is not intended to be a substitute for proven healthcare advice, trips or professional assistance by using a real medical. We aren't mDs. Always confer with your physician about Measurement Of Serum Levels Of Two Antiepileptic Drugs During Conversion In Patients With Epilepsy. conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Measurement Of Serum Levels Of Two Antiepileptic Drugs During Conversion In Patients With Epilepsy. Clinical research trials and Measurement Of Serum Levels Of Two Antiepileptic Drugs During Conversion In Patients With Epilepsy. medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectualness of new does drugs. The purpose of the studies / projects is to solve specific human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to discover treatments for all sorts of conditions, such as Measurement Of Serum Levels Of Two Antiepileptic Drugs During Conversion In Patients With Epilepsy.. Measurement Of Serum Levels Of Two Antiepileptic Drugs During Conversion In Patients With Epilepsy. Clinical Trials and other clinical trials permit volunteers to access healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for without cost, and every now and again they are compensated for their time. Sometimes there is a cost for a Measurement Of Serum Levels Of Two Antiepileptic Drugs During Conversion In Patients With Epilepsy. clinical trial. Subjects often receive the most expert healthcare possible for their Measurement Of Serum Levels Of Two Antiepileptic Drugs During Conversion In Patients With Epilepsy. condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, healthcare dangers (perhaps life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with stern guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "M" Clinical Trials Conditions > Measurement Of Serum Levels Of Two Antiepileptic Drugs During Conversion In Patients With Epilepsy.  Measurement Of Serum Levels Of Two Antiepileptic Drugs During Conversion In Patients With Epilepsy.
Measurement Of Serum Levels Of Two Antiepileptic Drugs During Conversion In Patients With Epilepsy.
For Condition: Epilepsy
Status: Completed
Sponsor(s): Sponsor Name Pending ,
Synopsis: This study includes patients 16 years of age or older with a confident diagnosis of epilespy who are currently treated with an antiepileptic drug (AED) monotherapy but require a change in therapy due to inadequate seizure control and/or unacceptable side effects.
Details:
Eligibility:
Study Type: Interventional, Treatment, Open Label, Single Group Assignment, Pharmacokinetics Study
Minimum Age/Maximum Age: 16 Years/
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA: (All of these criteria must be met in order to be eligible to participate in this study.) - 1) 16 years old or older. - 2) Have confident diagnosis of epilepsy. - 3) Have been on the medication valproate for at least 3 months and is currently on a stable daily dose. - 4) Male or female; females of child-bearing potential must have negative pregnancy test at screen and must agree to use an acceptable birth control method. EXCLUSION CRITERIA: (None of these criteria can be met in order to be eligible to participate in this study.) - A history of hypersentisitivity to the drug being studied. - Currently being treated with or has been treated in the past with the drug being studied. - Undergoing polytherapy treatment with the medication valproate and one or more other antiepileptic drug(s). - If undergong treatment with vagal nerve stimulation, has had device implanted more than 30 days prior to enrollment. - Has taken an investigational drug or the medication Felbatol within the previous 30 days. - Is abusing alcohol and/or other substances.
Total Enrollment:
Location and Contact Information:
Study Site
Panama City, Florida, 32405
United States
Study Site
Ft. Worth, Texas, 76107
United States
Study Site
San Antonio, Texas, 78229
United States
Study Site
Marrero, Louisiana, 70072
United States
Study Site
Tacoma, Washington, 98304
United States
Study Site
Seattle, Washington, 98122
United States
Study Site
Denver, Colorado, 80218
United States
Study Site
Decatur, Georgia, 30033
United States
Study Site
Augusta, Georgia, 30912
United States
Study Site
Newton Center, Massachusetts, 02446
United States
Study Site
Lexington, Kentucky, 40536
United States
Study Site
Huntsville, Alabama, 35801
United States
Study Site
Golden Valley, Minnesota, 55422
United States
Study Site
Miami, Florida, 33136
United States
Study Site
Jacksonville, Florida, 32209
United States
Study Site
Traverse City, Michigan, 49684
United States
Study Site
Memphis, Tennessee, 38105
United States
Study Site
Madison, Wisconsin, 53792
United States
Study Site
West Palm Beach, Florida, 33407
United States
Study Site
Austin, Texas, 80459
United States
Study Site
Little Rock, Arkansas, 72205
United States
Study Site
Atlanta, Georgia, 30338
United States
Study Site
Detroit, Michigan, 48202
United States
Study Site
Gainesville, Florida, 32608
United States
Additional Information:
Study ID Numbers: LAM40013;
Study Start Date:
Record last reviewed: January 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00043914
Other Epilepsy Studies:
1. Double-blind, placebo-controlled trial of vitamin E as add-on therapy for children with epilepsy
2. Study of Specimens Obtained during Epilepsy Surgery
3. Depression and Health Outcomes in Refractory Epilepsy
4. Brain Blood Flow Studies of Language and Memory
5. Monitoring Patients with Uncontrolled Epilepsy
Related Studies:
Other Epilepsy Clinical Trials
Other Washington Clinical Trials
Other Tacoma Clinical Trials
Measurement Of Serum Levels Of Two Antiepileptic Drugs During Conversion In Patients With Epilepsy.
|
|
|
|
|
|
|
|
